Doctors Revision

Chronic Inflammation: Causes, Cells, Macrophage Activation, Granulomas, Fibrosis and Clinical Features

Text size
On this page

Overview

Chronic Inflammation

Persistent injury • macrophages and lymphocytes • tissue destruction • repair and fibrosis • granulomas • systemic disease

Chronic inflammation is prolonged inflammation in which active inflammation, tissue destruction and repair occur at the same time. It may follow unresolved acute inflammation or begin insidiously with persistent infection, autoimmunity, foreign material, toxin exposure or metabolic stress. The response can continue for months or years and remodel an organ permanently.

Unlike acute inflammation, chronic inflammation is not defined only by duration. It is recognised by the combination of mononuclear inflammatory cells, ongoing tissue injury, angiogenesis and fibrosis.

Learning outcomes

  • Define chronic inflammation and distinguish it from acute and acute-on-chronic inflammation.
  • List major causes and explain why the stimulus persists.
  • Describe macrophage, lymphocyte, plasma-cell, eosinophil and mast-cell roles.
  • Explain M1/M2 macrophage activation, cytokine loops and fibrosis.
  • Recognise granulomatous inflammation and important causes.
  • Relate chronic inflammation to systemic disease, cancer, organ failure and emergency flares.
  • Outline diagnostic and management principles.

1. Hallmarks

Scroll the table sideways on a smaller screen.

Hallmarks
HallmarkWhat is seen?
Mononuclear infiltrateMacrophages, lymphocytes and plasma cells; variable eosinophils and mast cells.
Ongoing tissue destructionNecrosis, epithelial injury, parenchymal loss or vascular damage from the cause and inflammatory cells.
Repair and fibrosisAngiogenesis, fibroblast activation, collagen deposition and remodelling.
Persistent mediator networkTNF, IL-1, IFN-γ, IL-17, TGF-β, chemokines and growth factors.

2. Causes

Scroll the table sideways on a smaller screen.

Causes
CauseExamplesWhy it persists
Persistent infectionsTuberculosis, fungi, parasites, chronic viral hepatitis.Organism resists eradication or hides intracellularly.
AutoimmunityRheumatoid arthritis, SLE, inflammatory bowel disease.Self-antigen and memory immune responses continue.
Prolonged toxin exposureSilica, tobacco smoke, asbestos, drugs.Continued exposure or retained particles.
Foreign bodiesSutures, splinters, implants, crystals.Material cannot be degraded or removed.
Metabolic stressObesity, atherosclerosis, urate and cholesterol crystals.Lipotoxicity, inflammasomes and repeated tissue stress.
Unresolved acute inflammationChronic abscess, obstructed organ, persistent necrotic tissue.Source control is incomplete.

3. Macrophages: the central chronic cell

Monocytes enter tissue and differentiate into macrophages under the influence of chemokines and growth factors. Resident macrophages also expand locally. They ingest microbes and debris, present antigen and direct repair or fibrosis.

3.1 Classical (M1-like) activation

IFN-γ, microbial products and TNF produce an inflammatory phenotype. M1-like macrophages release ROS, NO, IL-1, TNF, IL-6, IL-12 and proteases. They are effective at microbial killing but can destroy host tissue.

3.2 Alternative (M2-like) activation

IL-4, IL-13 and other signals produce a repair/fibrotic phenotype. M2-like macrophages release TGF-β, VEGF, growth factors and matrix-remodelling enzymes. They support angiogenesis and wound healing but can cause excessive fibrosis and tumour support.

3.3 Macrophage self-amplification

Macrophages release chemokines that recruit monocytes and cytokines that activate lymphocytes. Lymphocytes release IFN-γ, IL-17 and other signals that further activate macrophages. This positive feedback loop sustains chronic inflammation after the initial trigger becomes difficult to detect.

4. Lymphocytes and other cells

Scroll the table sideways on a smaller screen.

Lymphocytes and other cells
CellFunction in chronic inflammation
T lymphocytesCD4 subsets activate macrophages or recruit neutrophils; CD8 cells kill target cells.
B cells/plasma cellsProduce antibodies; organise tertiary lymphoid structures; may drive immune complexes.
EosinophilsHelminth defence and allergy; granule proteins injure tissue.
Mast cellsRelease histamine, proteases and cytokines; participate in allergy and fibrosis.
NeutrophilsPersist in chronic infection, smoking-related disease and acute-on-chronic flares.
Fibroblasts/endotheliumProduce matrix, angiogenesis and remodelling signals.

5. Granulomatous inflammation

Granulomas are organised collections of epithelioid macrophages, often surrounded by lymphocytes and giant cells. They form when a stimulus is difficult to eradicate or when T-cell responses strongly activate macrophages.

Scroll the table sideways on a smaller screen.

Granulomatous inflammation
TypeExamplesDiagnostic approach
Caseating infectiousTuberculosis, histoplasmosis and other deep fungi.AFB/fungal stains, culture, PCR and exposure history.
Non-caseating immuneSarcoidosis, Crohn disease, beryllium.Exclude infection and foreign body; assess organ pattern.
Foreign-bodySuture, talc, splinter, keratin or crystals.Polarised light and search for material.

Granulomas can cause fibrosis, obstruction, vascular compromise and organ dysfunction. A biopsy pattern is not a complete diagnosis without microbiology and clinical correlation.

6. Tissue destruction and repair

  • Macrophage proteases and ROS destroy extracellular matrix and parenchymal cells.
  • TNF and IL-1 activate endothelium and sustain leukocyte recruitment.
  • VEGF promotes angiogenesis, while TGF-β activates fibroblasts and collagen deposition.
  • Matrix metalloproteinases degrade tissue; tissue inhibitors control remodelling.
  • Repeated injury and repair produce architectural distortion, strictures and loss of specialised function.

7. Fibrosis and organ consequences

Scroll the table sideways on a smaller screen.

Fibrosis and organ consequences
Organ/conditionChronic injury and consequence
LiverChronic hepatitis/steatohepatitis → bridging fibrosis, cirrhosis, portal hypertension.
LungInterstitial inflammation → collagen deposition, restrictive disease and hypoxia.
KidneyInterstitial inflammation → nephron loss, fibrosis and chronic kidney disease.
Heart/vesselsAtherosclerotic inflammation → plaque rupture, infarction and stroke.
GutCrohn disease/ulcerative colitis → strictures, fistulae, bleeding and malabsorption.
JointsRheumatoid synovitis → pannus, cartilage destruction and deformity.

8. Systemic effects

  • Persistent IL-6 and TNF cause anaemia of inflammation, thrombocytosis, fatigue and cachexia.
  • Chronic inflammation increases cardiovascular risk through endothelial activation and plaque instability.
  • Immune dysregulation produces fever, night sweats, weight loss and recurrent flares.
  • Chronic infection can produce amyloidosis through sustained serum amyloid A.
  • Inflammatory cytokines and oxidative stress promote DNA damage and cancer development.

9. Chronic inflammation and cancer

Persistent inflammatory signalling promotes angiogenesis, cell proliferation, DNA damage, matrix remodelling and immune evasion. Examples include H. pylori-associated gastric cancer, chronic hepatitis and hepatocellular carcinoma, inflammatory bowel disease and colorectal cancer, and chronic pancreatitis with pancreatic cancer risk.

10. Diagnosis

  1. History: duration, infection exposure, autoimmune symptoms, occupation, smoking, drugs and foreign material.
  2. Examination: organ-specific signs, lymphadenopathy, hepatosplenomegaly, joint changes, fibrosis and nutritional status.
  3. Laboratory: FBC, CRP/ESR, renal/liver function, autoantibodies, cultures, viral tests and targeted metabolic markers.
  4. Imaging: ultrasound, CT, MRI, endoscopy, echocardiography or pulmonary function tests for remodelling and fibrosis.
  5. Biopsy: identifies cell type, granuloma, fibrosis, organisms, vasculitis and neoplasia.

11. Management principles

  • Eradicate persistent infection with appropriate antimicrobials and source control.
  • Remove foreign bodies and stop toxin exposure, including smoking.
  • Use immunomodulation for proven autoimmune disease after excluding infection.
  • Control metabolic drivers such as obesity, diabetes, dyslipidaemia and hyperuricaemia.
  • Prevent and treat fibrosis complications; monitor organ function and cancer risk.
  • Rehabilitate with nutrition, exercise, vaccination and functional support.

12. Emergency flares

  • Sepsis on chronic liver, lung or kidney disease can cause rapid multi-organ failure.
  • Acute asthma or COPD exacerbation adds neutrophilic/eosinophilic inflammation to chronically remodelled airways.
  • Rheumatoid or inflammatory bowel flares may mimic infection; severe pain, bleeding or obstruction requires urgent review.
  • Decompensated cirrhosis, pulmonary fibrosis and chronic kidney disease have low reserve during acute injury.

13. Quick self-test

  1. What three features define chronic inflammation?
    Answer: Mononuclear infiltrate, ongoing tissue destruction and simultaneous repair/fibrosis.
  2. Name three causes of chronic inflammation.
    Answer: Persistent infection, autoimmunity, toxin/foreign body, metabolic stress or unresolved acute inflammation.
  3. What is the main role of M1-like macrophages?
    Answer: Microbial killing and inflammatory cytokine production.
  4. What is the risk of M2-like activation?
    Answer: Excessive fibrosis, remodelling and tumour-supporting angiogenesis.
  5. What is a granuloma?
    Answer: An organised collection of activated macrophages, usually with lymphocytes and giant cells.
  6. Why must infection be excluded before immunosuppression?
    Answer: Suppression can allow an occult infection to disseminate and cause organ failure.
  7. How does chronic inflammation promote cancer?
    Answer: Cytokines, ROS, proliferation, angiogenesis and matrix remodelling create a mutagenic, growth-supportive environment.

14. Take-home summary

  • Chronic inflammation combines persistent mononuclear inflammation, tissue destruction and repair/fibrosis.
  • Macrophages coordinate microbial killing, antigen presentation, lymphocyte activation and fibrosis.
  • Granulomas contain difficult-to-eradicate organisms, foreign material or immune stimuli.
  • Long-term inflammation causes organ remodelling, functional loss, systemic disease and increased cancer risk.
  • Management requires identifying the continuing stimulus, controlling infection/toxin/foreign body, treating immune disease and protecting organ reserve.

Selected references

Educational note: This resource supports learning and clinical reasoning. Current local protocols, senior supervision and national guidelines take precedence in patient care.

Lesson map

Further reading

For deeper study, compare this lesson with current guidance and standard references from recognised medical and public-health organisations.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top